Neuroprotective effects of peptides bioregulators in people of various age
Review of earlier studies · 2013
- What was studied
- Review of earlier research
- Main finding
- A gateway review comparing polypeptide complexes (Cortexin and Cerebrolysin) with short peptides (Semax, Cortagen and Pinealon). It discusses older populations and cellular mechanisms; the abstract supplies no trial-quality assessment.
Study data at a glance
- Participants or experimental model
- Review of earlier research
- Reported results
- A gateway review comparing polypeptide complexes (Cortexin and Cerebrolysin) with short peptides (Semax, Cortagen and Pinealon). It discusses older populations and cellular mechanisms; the abstract supplies no trial-quality assessment.
Study limitations and source details
Study limitations
- Source-linked does not mean a completed risk-of-bias review.
- A review is not an independent clinical replication; proposed mechanisms do not establish efficacy or safety.
Source details
Indexed English abstract checked; Russian full text not retrieved.
Sources checked
Citation
R. S. Umnov, N. S. Linkova, V. Kh. Khavinson. Neuroprotective effects of peptides bioregulators in people of various age Adv Gerontol. 26(4):671–678. PMID 24738258
Related compounds
Cortexin
A polypeptide extract of animal cerebral cortex. Its active material is a mixture of low-molecular-weight peptides studied in neurological rehabilitation, stroke and pediatric neurology.
Cerebrolysin
An injectable hydrolysate of porcine brain tissue containing small peptides and free amino acids. Clinical studies have examined recovery after stroke and cognition in Alzheimer’s disease.
Semax
A synthetic heptapeptide, Met–Glu–His–Phe–Pro–Gly–Pro (MEHFPGP). It combines residues 4–7 of adrenocorticotropic hormone (ACTH) with Pro–Gly–Pro and has been studied in ischemic stroke.
Cortagen
A synthetic tetrapeptide, Ala–Glu–Asp–Pro (AEDP), developed through research on Cortexin, a peptide mixture extracted from cerebral cortex.
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.